G

GI Innovation Inc
KOSDAQ:358570

Watchlist Manager
GI Innovation Inc
KOSDAQ:358570
Watchlist
Price: 17 610 KRW 3.96% Market Closed
Market Cap: 1.1T KRW

Operating Margin
GI Innovation Inc

-14 413.6%
Current
-25 463%
Average
-4.3%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-14 413.6%
=
Operating Profit
-48.7B
/
Revenue
338.1m

Operating Margin Across Competitors

No Stocks Found

GI Innovation Inc
Glance View

Market Cap
1.1T KRW
Industry
Biotechnology

GI Innovation, Inc. engages in the development of biopharmaceutical products. The company is headquartered in Seoul, Seoul and currently employs 88 full-time employees. The company went IPO on 2023-03-30. The firm is engaged in the business of generating revenue through license fees by technology transfer of new drug candidates in pre-clinical and early clinical stages. The core new drug pipeline includes products such as GI-101 immuno-oncology and GI-301 allergy treatment.

Intrinsic Value
Not Available
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-14 413.6%
=
Operating Profit
-48.7B
/
Revenue
338.1m
What is the Operating Margin of GI Innovation Inc?

Based on GI Innovation Inc's most recent financial statements, the company has Operating Margin of -14 413.6%.

Back to Top